To-042

N/A

Report date: 2023/05/22 10:17:05
NME

Base Information

Drug NameTo-042
Drug Alias NameTo-042
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bari Aldo Moro
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Bari Aldo Moro
Inactive CompaniesN/A
Active IndicationsMyotonic Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A